Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pacritinib Prior to Transplant for MPN
NCT02410551Phase 2Terminated
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Jun 2015
- Primary completion
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pacritinib in myelofibrosis (MF), sponsored by University of Texas MD Anderson Cancer Center. Started Jun 2015; status: terminated.
02
Drugs
pacritinib
03
Conditions
myelofibrosis (MF)
Beyond the preview
Go deeper on NCT02410551.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02410551.